Sheri L. Bonar - Concepedia

Concepedia

Author

Sheri L. Bonar

Pfizer (United States)

Also Known As

S L Bonar, SHERI L. BONAR, Sheri Bonar, Sheri L. Bonar

19

Publications

1.1K

Citations

16

H-Index

38

Concepts

All Affiliations

Pfizer (United States)Washington University in St. Louis University of California San Diego Monsanto (United States)Purdue University West Lafayette

SL

About

Sheri L. Bonar is an author at Pfizer (United States) specializing in medicine, natural sciences, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	191
2	Natural Sciences	3	3	111
3	Biochemistry	3	3	111
4	Engineering	1	1	38
5	Allergy	1	1	16

Sheri L. Bonar

×

17

Publications

1.1K

Citations

16

H-Index

	Year	Citations
A Selective IKK-2 Inhibitor Blocks NF-κB-dependent Gene Expression in Interleukin-1β-stimulated Synovial Fibroblasts Nandini Kishore, Cindy Sommers, Sumathy Mathialagan, Journal of Biological Chemistry	2003	273
JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production Timothy P. LaBranche, Michael I. Jesson, Chad Storer, Arthritis & Rheumatism	2012	130
Constitutively Activated NLRP3 Inflammasome Causes Inflammation and Abnormal Skeletal Development in Mice Sheri L. Bonar, Susannah Brydges, James L. Mueller, PLoS ONE	2012	124
Selective inhibition of the p38α MAPK–MK2 axis inhibits inflammatory cues including inflammasome priming signals Chun Wang, Susan L. Hockerman, E. Jon Jacobsen, The Journal of Experimental Medicine	2018	98
NLRP3 mediates osteolysis through inflammation‐dependent and ‐independent mechanisms Chao Qu, Sheri L. Bonar, Cynthia L. Hickman‐Brecks, The FASEB Journal	2014	73
Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase Shaun R. Selness, Rajesh Devraj, Balekudru Devadas, Bioorganic & Medicinal Chemistry Letters Drug TargetSignaling PathwayP38 Map KinaseBiochemistryPotent Inhibitor	2011	70
A Novel, Highly Selective, Tight Binding IκB Kinase-2 (IKK-2) Inhibitor: A Tool to Correlate IKK-2 Activity to the Fate and Functions of the Components of the Nuclear Factor-κB Pathway in Arthritis-Relevant Cells and Animal Models Gabriel Mbalaviele, Cynthia D. Sommers, Sheri L. Bonar, Journal of Pharmacology and Experimental Therapeutics	2009	61
Novel Insights into the Cellular Mechanisms of the Anti-inflammatory Effects of NF-κB Essential Modulator Binding Domain Peptides Eric T. Baima, Julia A. Guzova, Sumathy Mathialagan, Journal of Biological Chemistry	2010	40
Poly-ADP-ribosylation-mediated degradation of ARTD1 by the NLRP3 inflammasome is a prerequisite for osteoclast maturation C Wang, Chenling Qu, Yael Alippe, Cell Death and Disease	2016	39
Virulence of a Phosphoribosylaminoimidazole Carboxylase-Deficient <i>Candida</i> <i>albicans</i> Strain in an Immunosuppressed Murine Model of Systemic Candidiasis Matthew Donovan, Jon J. Schumuke, William A. Fonzi, Infection and Immunity Immunosuppressed Murine ModelPathogenic MicrobiologyEngineeringMicrobial PathogensFungal Cell Biology	2001	38

Page 1